The speaker shares their excitement about someone coming to witness the testing process and product launch in Texas, expresses gratitude to the guest and listeners, and provides a preview of the next episode. Includes an ad from Stamps.com promoting their shipping and mailing services.
The Sunday Times’ tech correspondent Danny Fortson brings on David Stein, chief executive of Babson Diagnostics, to talk about the importance of blood testing (4:49), why Babson is not Theranos (6:47), trying to compete with that idea (9:26), why they succeeded where Theranos failed (14:34), using a tiny amount of blood (18:23), fighting against the Theranos effect (24:37), being owned by a company they aim to disrupt (26:28), liquid biopsies (28:02), the new age of biological data (32:23), regulatory approval (37:09), and avoiding the spotlight (39:03).
Hosted on Acast. See acast.com/privacy for more information.